Wuhan KadWise Biotechnology Co., Ltd.
PrivateLast Round
Series C
Apr 7, 2026
Est. Valuation
$69.9M
Total Funding Raised
$101.36M
Company Overview
Wuhan KadWise Biotechnology Co., Ltd. is a biotechnology company that develops diagnostic and therapeutic solutions for gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan KadWise Biotechnology Co., Ltd. Comparables
Compare Wuhan KadWise Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Epiprobe Biotechnology Co., Ltd. | 87% | |
| Beijing OriginPoly Bio-Tec Co., Ltd. | 86% | |
| Guzip Biomarkers Corporation | 77% | |
Wuhan KadWise Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 7, 2026 | ||||
| Series B | Dec 5, 2024 | ||||
| Series A | Jun 1, 2022 | ||||
| Pre Seed | Apr 1, 2019 |
Wuhan KadWise Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongtai Capital Holdings | Series B |
| 招银国际金融有限公司 | Series C |
| Wuhan Hi-Tech Holding Group | Series B |
| 清控银杏创业投资管理（北京）有限公司 | Series C |
| Lengshanxi Capital | Series B |
| Hubei Provincial Science and Technology Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2024
$28M round led by Lengshanxi Capital.
- Jun 1, 2022
$30M round led by CSPC Pharmaceutical Group and Hangzhou Tigermed.
Wuhan KadWise Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wuhan KadWise Biotechnology Co., Ltd.'s valuation, stock price, and market status.